SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Corcept Therapeutics Reports Third-Quarter Financial Results and Corporate Update

Corcept Therapeutics reported third-quarter financial results and provided a corporate update.

CORT
SquawkNews Desk 2 updates Updated Nov 03, 2026, 09:08 PM UTC

Story updates

09:07:42 PM UTC
SquawkNews
Corcept Therapeutics 3Q EPS $1.01 >CORT
09:08:51 PM UTC
SquawkNews
Revenue of $340.5 million, a 64 percent increase over the same period in 2025 Korlym® and authorized

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today reported its results for the thi…

Related stories

Mosaic Reports Q3 Loss as Net Sales Decline Year Over Year Mosaic reported a net loss in Q3 2026, while net sales declined year over year. M impact | EQUITY | Nov 03, 2026, 10:28 PM UTC Champion Homes reports fiscal Q2 earnings of $52 Champion Homes reported earnings of $52. M impact | EQUITY | Nov 03, 2026, 10:20 PM UTC Corcept Therapeutics Q3 Earnings and Revenue Rise; Shares Fall After Hours Corcept Therapeutics reported higher Q3 earnings and revenue. Its shares fell after hours. M impact | EQUITY | Nov 03, 2026, 10:17 PM UTC AMD CEO Plans for Double-Digit PC Market Unit Shipment Decline in 2027 AMD’s CEO said the company is planning for PC market unit shipments to decline by a double-digit percentage in 2027. L impact | EQUITY | Nov 03, 2026, 10:15 PM UTC Riversgold requests trading halt ahead of capital raising announcement M impact | EQUITY | Nov 03, 2026, 10:15 PM UTC Seaboard reports third-quarter sales of $2.771 billion M impact | EQUITY | Nov 03, 2026, 10:15 PM UTC